BISORB®Drug-Eluting Sinus Absorbable Stent System Gains International Recognition Again, Approved for Registration in Colombia
Date：2024-06-12 17:32:03
“BISORB®Drug-Eluting Sinus Absorbable Stent System Gains International Recognition Again, Approved for Registration in Colombia
On May 31, 2024, Puyi (Shanghai) Biotech Co., Ltd. achieved another breakthrough in the field of medical innovation by obtaining approval from the Colombian authorities for the marketing of its Xiangtong Fully Biodegradable Drug-Eluting Sinus Stent System. The registered name of the product in Colombia is "Drug-eluting sinus absorbable stent system/Sistema de stent liberador de fármacos absorbible de senos paranasales". This is the fourth registration certificate obtained by Puyi Bio in overseas markets after Indonesia, Philippines, and Thailand. The product has been reviewed by INVIMA and meets the market access requirements, indicating a further enhancement of Puyi Bio's international influence in the medical device field.
The Xiangtong Fully Biodegradable Drug-Eluting Sinus Stent System is a high-tech medical device independently developed by Puyi Bio, specifically designed for patients with chronic rhinosinusitis (CRS) undergoing endoscopic sinus surgery (ESS). The product is implanted into the target site during and after surgery, not only supporting the separated wound surface and fixing the repaired mucosal flap but also controlling edema, preventing adhesions, maintaining drainage, continuously fighting inflammation at the target site, and promoting healing through sustained release of hormones. Obtaining registration approval in Colombia indicates that the product has passed strict scrutiny and meets the market access requirements.
This registration approval will not only benefit more Colombian patients but also provide strong support for Puyi Bio's further expansion in the Colombian market. Puyi Bio will continue to develop more innovative medical devices, injecting new vitality into global healthcare.
